2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Bronchiectasis: new trials by email Literature Review of Bronchiectasis trials Research Report on Bronchiectasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis XH-S004 20 mg, XH-S004 40 mg, Placebo - Non-Cystic Fibrosis Bronchiectasis | Phase 2 | Active not recruiting | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 234 | 2025-05-30 | 2026-09-25 |
| Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine BI 1291583, Placebo matching BI 1291583 - Bronchiectasis | Phase 2 | Active not recruiting | Boehringer Ingelheim | 268 | 2023-09-08 | 2026-10-14 |
Fibrosis (1)
Bronchial Diseases (2) · Respiratory Tract Diseases (2) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Boehringer Ingelheim (1) · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (1)
Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · China (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Japan (1) · Latvia (1) · Mexico (1)
2023 (1)